X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
ALEMBIC LTD Fact Sheet, ALEMBIC LTD Financial Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD Fact Sheet   (ALMC)

Here is the latest financial fact sheet of ALEMBIC LTD. For more details, see the ALEMBIC LTD quarterly results and ALEMBIC LTD share price and chart. For a sector overview, read our pharmaceuticals sector report.

ALEMBIC LTD Price History

Price Rs 40.2
Mkt Cap Rs m 22,235
Vol '000 110.0
P/E X 80.9
P/CF X 72.2
EPS (TTM) Rs 0.5
% ch % -1.0
No. of shares m 553.80
% ch week % -1.2
% ch 1-mth % 0.4
% ch 12-mth % 4.3
52 week H/L Rs 51.7/32.4
(As on Jul 21, 2017 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ALEMBIC LTD Financials

No. of Mths
Year Ending
12
Mar-12
12
Mar-13
12
Mar-14
12
Mar-15
*
12
Mar-16
*
5-Yr Chart
Click to enlarge
ALEMBIC LTD EQUITY SHARE DATA
High Rs4020187053 
Low Rs141471629 
Sales per share (Unadj.) Rs9.013.45.85.44.7 
Earnings per share (Unadj.) Rs-0.90.91.14.08.8 
Diluted earnings per shareRs-0.20.20.51.94.2 
Cash flow per share (Unadj.) Rs-0.11.61.24.29.0 
Dividends per share (Unadj.) Rs00.200.150.150.15 
Adj. dividends per shareRs0.000.050.070.070.07 
Dividend yield (eoy) %01.21.20.30.4 
Book value per share (Unadj.) Rs14.815.48.619.827.7 
Adj. book value per shareRs3.63.74.29.513.4 
Shares outstanding (eoy) m133.52133.52267.03267.03267.03 
Bonus/Rights/Conversions  --B1:1-- 
Price / Sales ratio x3.01.32.18.08.7 
Avg P/E ratio x-29.519.811.210.84.7 
P/CF ratio (eoy) x-283.910.610.410.24.6 
Price / Book Value ratio x1.81.11.42.21.5 
Dividend payout %023.213.63.81.7 
Avg Mkt Cap Rs m3,6052,2703,29811,46910,962 
No. of employees `000NANANANANA 
Total wages/salary Rs m255245273270238 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
ALEMBIC LTD INCOME DATA
Net Sales Rs m1,2081,7921,5361,4391,260 
Other income Rs m65103158208264 
Total revenues Rs m1,2721,8951,6941,6471,524 
Gross profit Rs m-151572239583 
Depreciation Rs m10998236061 
Interest Rs m52512380 
Profit before tax Rs m-111110335235285 
Minority Interest Rs m00000 
Prior Period Items Rs m0008252,096 
Extraordinary Inc (Exp) Rs m-25000-32 
Tax Rs m-14-539-76 
Profit after tax Rs m-1221152951,0662,343 
Gross profit margin %-1.28.714.56.66.6 
Effective tax rate %12.7-4.411.8-2.92.1 
Net profit margin %-10.16.419.274.1185.9 
ALEMBIC LTD BALANCE SHEET DATA
Current assets Rs m1,7001,2901,5431,6091,689 
Current liabilities Rs m1,6311,070907533486 
Net working cap to sales %5.712.341.474.895.4 
Current ratio x1.01.21.73.03.5 
Inventory Days Days285198248214217 
Debtors Days Days48376612281 
Net fixed assets Rs m1,9541,8841,8001,7151,624 
Share capital Rs m267267534534534 
"Free" reserves Rs m4988928743,8395,960 
Net worth Rs m1,9722,0582,3075,2787,404 
Long term debt Rs m0302331354104 
Total assets Rs m3,9153,4403,5626,1928,010 
Interest coverage x-1.13.115.429.3950.7 
Debt to equity ratio x00.10.10.10 
Sales to assets ratio x0.30.50.40.20.2 
Return on assets %-1.84.88.917.429.3 
Return on equity %-6.25.612.820.231.6 
Return on capital %-4.36.813.619.031.3 
Exports to sales %7.14.47.714.32.9 
Imports to sales %5.40.93.42.528.9 
Exports (fob) Rs m867911820537 
Imports (cif) Rs m66175237364 
Fx inflow Rs m867911820537 
Fx outflow Rs m70386342365 
Net fx Rs m164155163-328 
ALEMBIC LTD CASH FLOW
From Operations Rs m -591 803 -102 220 346 
From Investments Rs m -54 121 178 47 -48 
From Financial Activity Rs m 646 -943 -79 -250 -301 
Net Cashflow Rs m 1 -19 -3 17 -3 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 64.0%
Foreign collaborators 0.0%
Indian inst/Mut Fund 0.2%
FIIs 9.7%
ADR/GDR 0.0%
Free float 26.1%
Shareholders 54,701
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Alembic Road, Vadodara - 390 003
E-MAIL alembic.investors@alembic.co.in WEB www.alembiclimited.com
TELEPHONE (0265) 228 0550 FAX (0265) 228 2506
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Link Intime India, B-102-103, Shangrila Complex, 1st Flr., Akota, Vadodara-20
AUDITOR K. S. Aiyar & Co.
CHM: Chirayu R. Amin (MD) COMP SEC: Chirag K. Shukla YEAR OF INC: 1907 BSE CODE: 506235 FV (Rs): 2 DIV YIELD (%): 0.2

More Pharmaceuticals Company Fact Sheets:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  FDC LTD.  PIRAMAL ENTERPRISES  J.B.CHEMICALS  

Compare ALEMBIC LTD With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  FDC LTD.  PIRAMAL ENTERPRISES  J.B.CHEMICALS  

Compare ALEMBIC LTD With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Stronger Euro Drags European Markets(RoundUp)

The strength of the euro does appear to be acting as a bit of a headwind for European stocks as they look to close the week sharply lower in contrast to the performance of UK and US stocks this week.

Views on news

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

More Views on News

Most Popular

Post Demonetisation Real Estate Sales Have Collapsed, But Prices Haven't(Vivek Kaul's Diary)

Jul 11, 2017

While sales have fallen dramatically, net net home prices continue to hold on.

Ride the Bull Wave with These Perfect Proxies to India's Growth Story(The 5 Minute Wrapup)

Jul 15, 2017

The secret of spotting multibaggers before they become a hit.

The New Pharma Rally Starts NOW(Daily Profit Hunter)

Jul 12, 2017

The most hated sector is offering the best trading opportunity. Are you ready?

All You Need To Know To e-File Your Income Tax Returns(Outside View)

Jul 12, 2017

The Income Tax return filing deadline is drawing near; if you have not already filed your taxes, here's how to do it.

Warren Buffett's Long Term Returns Immune to Volatility(Chart Of The Day)

Jul 8, 2017

Buffett's periodic underperformance to index fund.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC LTD

ALEMBIC LTD 8-QTR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS